We are live on
!
Find out more
IHAM
Integral Health Asset Management Portfolio holdings
AUM
$2.09B
1-Year Est. Return
112.84%
This Fund
S&P 500
This Quarter
Est. Return
+21.57%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$734M
AUM Growth
+$11.9M
(+1.7%)
Cap. Flow
-$87.4M
Cap. Flow
% of AUM
-11.9%
Top 10 Holdings %
Top 10 Hldgs %
32.05%
Holding
98
New
33
Increased
14
Reduced
20
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$24.8M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$20.6M |
| 3 |
Sanofi
SNY
|
+$19.6M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$19M |
| 5 |
Teleflex
TFX
|
+$15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
argenx
ARGX
|
+$34.4M |
| 2 |
McKesson
MCK
|
+$21.7M |
| 3 |
Cytokinetics
CYTK
|
+$21.7M |
| 4 |
Amgen
AMGN
|
+$17.5M |
| 5 |
Cigna
CI
|
+$17.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 94.31% |
| 2 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
CRISPR Therapeutics
CRSP
$5.23B
| – | – |
-275,000
| Closed | -$12.5M |
|
|
ETNB
77
CALL
DELISTED
89bio
ETNB
| – | – |
-200,000
| Closed | -$3.09M |
|
78
Guardant Health
GH
$22.2B
| – | – |
-325,000
| Closed | -$9.63M |
|
79
HCA Healthcare
HCA
$89.1B
| – | – |
-10,000
| Closed | -$2.46M |
|
80
Lifestance Health
LFST
$4.39B
| – | – |
-1,300,000
| Closed | -$8.93M |
|
|
81
McKesson
MCK
$105B
| – | – |
-50,000
| Closed | -$21.7M |
|
82
PUT
MoonLake Immunotherapeutics
MLTX
$1.41B
| – | – |
-150,000
| Closed | -$8.55M |
|
83
Molina Healthcare
MOH
$10.2B
| – | – |
-35,000
| Closed | -$11.5M |
|
84
Merck
MRK
$322B
| – | – |
-50,000
| Closed | -$5.15M |
|
85
Envista
NVST
$4.58B
| – | – |
-150,000
| Closed | -$4.18M |
|
86
Pacific Biosciences
PACB
$354M
| – | – |
-800,000
| Closed | -$6.68M |
|
87
Pfizer
PFE
$152B
| – | – |
-150,000
| Closed | -$4.98M |
|
88
Replimune Group
REPL
$1.15B
| – | – |
-250,000
| Closed | -$4.28M |
|
89
Roivant Sciences
ROIV
$25.5B
| – | – |
-450,000
| Closed | -$5.26M |
|
90
Revvity
RVTY
$12.9B
| – | – |
-100,000
| Closed | -$11.1M |
|
91
CALL
Sarepta Therapeutics
SRPT
$1.92B
| – | – |
-50,000
| Closed | -$6.06M |
|
92
Supernus Pharmaceuticals
SUPN
$2.73B
| – | – |
-220,000
| Closed | -$6.07M |
|
93
Teva Pharmaceuticals
TEVA
$42.5B
| – | – |
-1,000,000
| Closed | -$10.2M |
|
94
Tandem Diabetes Care
TNDM
$1.63B
| – | – |
-130,000
| Closed | -$2.7M |
|
|
WW
95
DELISTED
WW International
WW
| – | – |
-250,000
| Closed | -$2.77M |
|
96
Zoetis
ZTS
$31.1B
| – | – |
-20,000
| Closed | -$3.48M |
|
|
CTLT
97
DELISTED
CATALENT, INC.
CTLT
| – | – |
-160,000
| Closed | -$7.28M |
|
|
SILK
98
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| – | – |
-150,000
| Closed | -$2.25M |
|
Similar funds
CL
ACM
ACG
NSUP
TP
ACP
TA
AG
Integral Health Asset Management's Q4 2023 Portfolio in Review
As of Q4 2023, Integral Health Asset Management held 98 positions worth $734M, up 1.7% from $722M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Integral Health Asset Management withdrew a net $87.4M in Q4 2023, closing 29 positions and reducing 20 holdings. Its most notable exit was argenx, an estimated $34.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 97% a quarter earlier, followed by Consumer Discretionary.
Against the trend, Integral Health Asset Management opened a new position in AbbVie worth $26.3M.
- Integral Health Asset Management's largest Q4 2023 buy was AbbVie: 170,000 shares worth $26.3M.
- Integral Health Asset Management added most to Walgreens Boots Alliance in Q4 2023, an estimated $19M increase.
- Integral Health Asset Management's biggest Q4 2023 reduction was Cytokinetics, cutting an estimated $21.7M.
- Integral Health Asset Management fully exited argenx in Q4 2023, selling an estimated $34.4M.
- Integral Health Asset Management's ten largest holdings make up 32% of its $734M portfolio in Q4 2023.
- Integral Health Asset Management opened 33 new positions and closed 29 in Q4 2023.
- Integral Health Asset Management's portfolio value rose 1.7% quarter-over-quarter to $734M.
Based on Integral Health Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.